US2009093622A1PendingUtilityA1

BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis

Assignee: RUELLE JEAN-LOUISPriority: May 13, 1998Filed: Dec 7, 2007Published: Apr 9, 2009
Est. expiryMay 13, 2018(expired)· nominal 20-yr term from priority
A61P 31/04A61K 2039/53C07K 14/22G01N 33/56911C12Q 1/689A61K 2039/51A61K 2039/505A61K 39/00C07K 16/1217C12N 15/11
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides BASB029 polypeptides and polynucleotides encoding BASB029 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.

Claims

exact text as granted — not AI-modified
1 - 34 . (canceled) 
   
   
       35 . An isolated polynucleotide encoding an immunogenic fragment of at least 15 contiguous amino acids of SEQ ID NO: 2. 
   
   
       36 . The polynucleotide of  claim 35  wherein said polynucleotide encodes an immunogenic fragment of at least 20 contiguous amino acids of SEQ ID NO: 2. 
   
   
       37 . An isolated polynucleotide selected from the group consisting of:
 (a) an isolated polynucleotide encoding SEQ ID NO: 4; and   (b) an isolated polynucleotide encoding an immunogenic fragment of at least 15 contiguous amino acids of SEQ ID NO: 4.   
   
   
       38 . The polynucleotide of  claim 37  wherein said polynucleotide is according to (a). 
   
   
       39 . The polynucleotide of  claim 37  wherein said polynucleotide is according to (b). 
   
   
       40 . The polynucleotide of  claim 39  wherein said polynucleotide encodes an immunogenic fragment of at least 20 contiguous amino acids of SEQ ID NO: 4. 
   
   
       41 . An isolated polynucleotide selected from the group consisting of:
 (a) a polynucleotide having the sequence SEQ ID NO: 3; and   (b) a polynucleotide fragment of the polynucleotide having the sequence SEQ ID NO: 3, wherein said fragment encodes an immunogenic fragment of at least 15 contiguous amino acids of a polypeptide having the amino acid sequence SEQ ID NO: 4.   
   
   
       42 . The polynucleotide of  claim 41  wherein said polynucleotide is according to (a). 
   
   
       43 . The polynucleotide of  claim 41  wherein said polynucleotide is according to (b). 
   
   
       44 . The polynucleotide of  claim 43  wherein said fragment encodes an immunogenic fragment of at least 20 contiguous amino acids of a polypeptide having the amino acid sequence SEQ ID NO: 4.

Join the waitlist — get patent alerts

Track US2009093622A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.